Brief: Mithra Pharmaceuticals SA - Transparency Notification From Goldman Sachs Group Inc.
22/12/2023 16:52
Dec 22 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* PUBLICATION OF A TRANSPARENCY NOTIFICATION RECEIVED FROM
GOLDMAN
SACHS GROUP INC.
* GOLDMAN SACHS GROUP, INC. NOTIFIED MITHRA THAT IT HAS
DROPPED
BELOW STATUTORY NOTIFICATION-THRESHOLD OF 3% OF 69,108,397
SHARES CURRENTLY OUTSTANDING ON 13 DECEMBER 2023 TO 2.99% (2 065
335 SHARES) OF SHARES OUTSTANDING
* PREVIOUSLY, GOLDMAN SACHS GROUP, INC. HELD 3.41% (2 359
668
SHARES) OF MITHRA'S OUTSTANDING SECURITIES.
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO